Pulmonary Large Cell Neuroendocrine Carcinoma: a unique type of lung cancer? Identification of molecular and clinical subtypes & consequences for treatment

Bregtje Catharina Maria Hermans

Research output: ThesisDoctoral ThesisInternal

181 Downloads (Pure)

Abstract

About 1-3% of all new cases of lung cancer are large cell neuroendocrine carcinoma (LCNEC). This is an aggressive form of lung cancer; patients with metastatic disease have an average of 4-9 months to live after diagnosis. The treatment for them currently consists of chemotherapy as we also use for other forms of lung cancer. This dissertation studied similarities and differences between LCNEC and other forms of (lung) cancer. Through more clarity about these similarities and differences, it can be better predicted to which type of treatment LCNEC patients will respond well. Also, different subgroups of LCNEC are distinguished. Patients in these subgroups may also benefit from a slightly different treatment. LCNEC appears to be a form of lung cancer with unique characteristics, but also with a clear overlap with other forms of lung cancer.
Original languageEnglish
Awarding Institution
  • Maastricht University
Supervisors/Advisors
  • Dingemans, A.M.C., Supervisor
  • Speel, Ernst, Supervisor
  • Derks, Jules, Co-Supervisor
Award date6 Jul 2021
Place of PublicationMaastricht
Publisher
Print ISBNs9789464166149
DOIs
Publication statusPublished - 2021

Keywords

  • LCNEC
  • neuroendocrine
  • lung cancer
  • carcinoid

Cite this